Utility of Left Bundle Branch Block as a Diagnostic Criterion for Acute Myocardial Infarction

Published:February 08, 2011DOI:https://doi.org/10.1016/j.amjcard.2010.12.007
      The clinical utility of new or “presumably new” left bundle branch block (LBBB) as an electrocardiographic criterion equivalent to ST-segment elevation myocardial infarction in contemporary practice is not well established. The aim of this study was to investigate the hypothesis that new or presumably new LBBB in symptomatic patients frequently leads to an overdiagnosis of acute myocardial infarction (AMI). A retrospective analysis of data from consecutive patients in the Mayo Clinic's ST-segment elevation myocardial infarction network from July 2004 to August 2009 was conducted among 892 patients, 36 (4%) of whom had new LBBB. The frequency, clinical characteristics, serum troponin levels, coronary angiographic findings, and outcomes of patients with new LBBB suspected of having AMI were evaluated. Compared with patients without LBBB (n = 856), those with new LBBB were older (64.5 vs 72.9 years, p <0.001), had higher Thrombolysis In Myocardial Infarction (TIMI) risk scores (22.7 vs 31.0, p <0.005), were less likely to undergo primary percutaneous coronary intervention (86% vs 22%, p <0.001), and had longer door-to-balloon times. Only 14 patients (39%) had final diagnoses of acute coronary syndromes, of which 12 were AMI, while 13 (36%) had cardiac diagnoses other than acute coronary syndrome and 9 (25%) had noncardiac diagnoses. Of the patients with AMI, 5 had occluded culprit arteries, of which 2 involved the left anterior descending coronary artery. A Sgarbossa score ≥5 had low sensitivity (14%) but 100% specificity in diagnosing AMI in the presence of new LBBB. In conclusion, new or presumably new LBBB in patients suspected of having AMI identifies a high-risk subgroup, but only a small number have AMI. Two thirds of these patients are discharged from the hospital with alternative diagnoses. The Sgarbossa criteria appear to have limited utility in clinical practice because of their low sensitivity.
      To read this article in full you will need to make a payment

      References

        • Fibrinolytic Therapy Trialists' (FTT) Collaborative Group
        Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients.
        Lancet. 1994; 343: 311-322
        • Al-Faleh H.
        • Fu Y.
        • Wagner G.
        • Goodman S.
        • Sgarbossa E.
        • Granger C.
        • Van de Werf F.
        • Wallentin L.
        • Armstrong P.W.
        Unraveling the spectrum of left bundle branch block in acute myocardial infarction: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT 2 and 3) trials.
        Am Heart J. 2006; 151: 10-15
        • Wong C.K.
        • French J.K.
        • Aylward P.E.
        • Stewart R.A.
        • Gao W.
        • Armstrong P.W.
        • Van De Werf F.J.
        • Simes R.J.
        • Raffel O.C.
        • Granger C.B.
        • Califf R.M.
        • White H.D.
        Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes.
        J Am Coll Cardiol. 2005; 46: 29-38
        • Ting H.H.
        • Rihal C.S.
        • Gersh B.J.
        • Haro L.H.
        • Bjerke C.M.
        • Lennon R.J.
        • Lim C.C.
        • Bresnahan J.F.
        • Jaffe A.S.
        • Holmes D.R.
        • Bell M.R.
        Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI protocol.
        Circulation. 2007; 116: 729-736
        • Sgarbossa E.B.
        • Pinski S.L.
        • Barbagelata A.
        • Underwood D.A.
        • Gates K.B.
        • Topol E.J.
        • Califf R.M.
        • Wagner G.S.
        • GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators
        Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block.
        N Engl J Med. 1996; 334: 481-487
        • Morrow D.A.
        • Antman E.M.
        • Giugliano R.P.
        • Cairns R.
        • Charlesworth A.
        • Murphy S.A.
        • de Lemos J.A.
        • McCabe C.H.
        • Braunwald E.
        A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy.
        Lancet. 2001; 358: 1571-1575
        • Lloyd-Jones D.
        • Adams R.J.
        • Brown T.M.
        • Carnethon M.
        • Dai S.
        • De Simone G.
        • Ferguson T.B.
        • Ford E.
        • Furie K.
        • Gillespie C.
        • Go A.
        • Greenlund K.
        • Haase N.
        • Hailpern S.
        • Ho P.M.
        • Howard V.
        • Kissela B.
        • Kittner S.
        • Lackland D.
        • Lisabeth L.
        • Marelli A.
        • McDermott M.M.
        • Meigs J.
        • Mozaffarian D.
        • Mussolino M.
        • Nichol G.
        • Roger V.L.
        • Rosamond W.
        • Sacco R.
        • Sorlie P.
        • Stafford R.
        • Thom T.
        • Wasserthiel-Smoller S.
        • Wong N.D.
        • Wylie-Rosett J.
        Executive summary: heart disease and stroke statistics—2010 update: a report from the American Heart Association.
        Circulation. 2010; 121: 948-954
        • Antman E.M.
        • Anbe D.T.
        • Armstrong P.W.
        • Bates E.R.
        • Green L.A.
        • Hand M.
        • Hochman J.S.
        • Krumholz H.M.
        • Kushner F.G.
        • Lamas G.A.
        • Mullany C.J.
        • Ornato J.P.
        • Pearle D.L.
        • Sloan M.A.
        • Smith Jr, S.C.
        • Alpert J.S.
        • Anderson J.L.
        • Faxon D.P.
        • Fuster V.
        • Gibbons R.J.
        • Gregoratos G.
        • Halperin J.L.
        • Hiratzka L.F.
        • Hunt S.A.
        • Jacobs A.K.
        ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction).
        Circulation. 2004; 110: e82-e292
        • Jacobs A.K.
        • Antman E.M.
        • Faxon D.P.
        • Gregory T.
        • Solis P.
        Development of systems of care for ST-elevation myocardial infarction patients: executive summary.
        Circulation. 2007; 116: 217-230
        • Larson D.M.
        • Menssen K.M.
        • Sharkey S.W.
        • Duval S.
        • Schwartz R.S.
        • Harris J.
        • Meland J.T.
        • Unger B.T.
        • Henry T.D.
        “False-positive” cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction.
        JAMA. 2007; 298: 2754-2760
        • Tabas J.A.
        • Rodriguez R.M.
        • Seligman H.K.
        • Goldschlager N.F.
        Electrocardiographic criteria for detecting acute myocardial infarction in patients with left bundle branch block: a meta-analysis.
        Ann Emerg Med. 2008; 52: 329-336
        • Frink R.J.
        • James T.N.
        Normal blood supply to the human His bundle and proximal bundle branches.
        Circulation. 1973; 47: 8-18